SCHEMBL26884098

SCHEMBL26884098

Cc1ccc(-c2csc(NC(=O)Cc3cnccn3)n2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WNT3A P56704 3/20 0.58
▸ SLC12A2 P55011 1/20 0.56
▸ SLC12A5 Q9H2X9 1/20 0.56
▸ HDAC1 Q13547 1/20 0.55
▸ HDAC9 Q9UKV0 1/20 0.55
▸ CLK1 P49759 1/20 0.54
▸ ROCK1 Q13464 3/20 0.54
▸ PRKACA P17612 1/20 0.54
▸ KMT2A Q03164 4/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ LMNA P02545 1/20 0.54
▸ CDC25A P30304 1/20 0.54
▸ CDC25B P30305 1/20 0.54
▸ CDC25C P30307 1/20 0.54
▸ HTT P42858 1/20 0.54
▸ NPC1 O15118 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26884092 0.85 SLC12A2 (0.64) WNT3ASLC12A2SLC12A5HDAC1HDAC9
SCHEMBL22728498 0.81 LMNA (0.78) ROCK1KMT2AMEN1LMNACDC25A
SCHEMBL14085825 0.78 HDAC1 (0.67) HDAC1HDAC9CLK1KMT2AMEN1
SCHEMBL28643881 0.77 HDAC1 (0.66) HDAC1HDAC9CLK1KMT2AMEN1
SCHEMBL21226526 0.77 HDAC1 (0.66) HDAC1HDAC9CLK1KMT2AMEN1
SCHEMBL7929906 0.77 HDAC1 (0.73) HDAC1HDAC9CLK1KMT2AMEN1
SCHEMBL26884095 0.76 KMT2A (0.67) WNT3ASLC12A2SLC12A5HDAC1HDAC9
SCHEMBL21484709 0.76 ABL1 (0.69) HDAC1HDAC9CLK1KMT2AMEN1
SCHEMBL12303088 0.76 WNT3A (0.86) WNT3AROCK1PRKACAKMT2AMEN1
SCHEMBL4420194 0.76 HDAC1 (0.65) WNT3AHDAC1HDAC9CLK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382903-A1 SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS, TOPICAL FORMULATIONS AND METHOD OF USE THEREOF CARTHRONIX INC (US) 2023-11-30 — — US disclosed
US-20230382903-A1 SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS, TOPICAL FORMULATIONS AND METHOD OF USE THEREOF CARTHRONIX INC (US) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382903-A1 SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS, TOPICAL FORMULATIONS AND METHOD OF USE THEREOF STAT1, STAT3, STAT6 WNT3A 1598/4885SLC12A2 3013/4885SLC12A5 2934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback